Equities research analysts expect Davita Inc (NYSE:DVA) to announce sales of $2.85 billion for the current quarter, according to Zacks Investment Research. Six analysts have provided estimates for Davita’s earnings, with estimates ranging from $2.83 billion to $2.87 billion. Davita also posted sales of $2.85 billion during the same quarter last year. The company is expected to announce its next earnings report on Wednesday, November 6th.
According to Zacks, analysts expect that Davita will report full-year sales of $11.35 billion for the current financial year, with estimates ranging from $11.28 billion to $11.39 billion. For the next financial year, analysts anticipate that the company will report sales of $11.58 billion, with estimates ranging from $11.34 billion to $11.81 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that follow Davita.
Davita (NYSE:DVA) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.22 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.12. The business had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.86 billion. Davita had a return on equity of 14.67% and a net margin of 1.21%. The business’s revenue was down 1.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.05 earnings per share.
Several equities research analysts recently commented on the company. Robert W. Baird cut Davita from an “outperform” rating to a “neutral” rating and dropped their target price for the stock from $70.00 to $65.00 in a report on Friday, July 26th. UBS Group dropped their target price on Davita from $61.00 to $60.00 and set a “neutral” rating on the stock in a report on Thursday, August 22nd. SunTrust Banks reissued a “hold” rating and set a $68.00 target price on shares of Davita in a report on Wednesday. ValuEngine cut Davita from a “hold” rating to a “sell” rating in a report on Tuesday, August 20th. Finally, William Blair cut Davita from an “outperform” rating to a “market perform” rating in a report on Wednesday. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company. Davita currently has an average rating of “Hold” and a consensus target price of $67.31.
Shares of NYSE DVA traded up $0.49 during midday trading on Monday, hitting $60.30. 2,681,741 shares of the company’s stock were exchanged, compared to its average volume of 2,201,468. Davita has a twelve month low of $43.40 and a twelve month high of $79.11. The firm has a market cap of $9.63 billion, a P/E ratio of 16.89, a PEG ratio of 0.58 and a beta of 1.59. The stock’s 50 day moving average price is $58.24 and its 200-day moving average price is $54.37. The company has a debt-to-equity ratio of 1.90, a current ratio of 1.12 and a quick ratio of 1.10.
A number of large investors have recently made changes to their positions in DVA. Vanguard Group Inc. lifted its position in Davita by 0.5% during the 2nd quarter. Vanguard Group Inc. now owns 13,652,940 shares of the company’s stock worth $768,114,000 after acquiring an additional 64,415 shares during the period. Par Capital Management Inc. raised its stake in shares of Davita by 40.6% during the 2nd quarter. Par Capital Management Inc. now owns 4,159,000 shares of the company’s stock worth $233,985,000 after buying an additional 1,201,300 shares in the last quarter. Invesco Ltd. raised its stake in shares of Davita by 56.2% during the 2nd quarter. Invesco Ltd. now owns 3,662,685 shares of the company’s stock worth $206,063,000 after buying an additional 1,317,725 shares in the last quarter. Viking Global Investors LP raised its stake in shares of Davita by 5.5% during the 2nd quarter. Viking Global Investors LP now owns 2,907,034 shares of the company’s stock worth $163,550,000 after buying an additional 151,529 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Davita by 0.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,579,221 shares of the company’s stock worth $132,708,000 after buying an additional 7,907 shares in the last quarter. 91.47% of the stock is currently owned by hedge funds and other institutional investors.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Further Reading: Why does a company issue an IPO?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.